Takeda to end collaboration with Orexigen
May 13, 2015 at 15:05 PM EDT
Takeda
Pharmaceutical has informed Orexigen Therapeutics Inc. (Nasdaq: OREX)
that Takeda will end their collaboration agreement sending the stock
price tumbling 93 cents to $5.00.